Cannabis and the Current State of Treatment for Cannabis Use Disorder.
Cannabis and the Current State of Treatment for Cannabis Use Disorder.
复制标题
大麻和大麻使用障碍的治疗现状。
DOI：
10.1176/appi.focus.20180038
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Hill,KevinP
中科院分区：
文献类型：
--
作者：
Williams,ArthurRobin;Hill,KevinP
尽管阿片类药物的流行可能会成为更多的全国性新闻头条，但在过去的20年里，大麻政策发生了一场革命，这场革命主要是由公众和商业利益推动的。因此，全国吸食大麻的人数--尤其是重度吸食者--每年都在增长。尽管不像因阿片类药物相关过量或阿片类药物使用障碍而进入急诊科的患者那么明显，但据估计，美国每年有450万至700万人符合大麻使用障碍的标准。这篇文章着重于大麻使用障碍的发展途径，在国家法律迅速变化的背景下青少年和成年人使用大麻的流行病学，以及普通精神病学家的循证治疗。作者提供了对该障碍患者的药物和心理社会行为治疗的概述，同时强调了这一患者群体特有的临床管理方面。
Although the opioid epidemic may command more national headlines, the past two decades have seen a revolution in cannabis policy driven largely by the public and by business interests. As a result, the population of cannabis users nationwide—especially of heavy users—has grown yearly. Although less visible than patients admitted to the emergency department for opioid-related overdose or to treatment for opioid use disorder, an estimated 4.5–7 million individuals in the United States are thought to meet criteria for cannabis use disorder in a given year. This article focuses on the developmental pathways of cannabis use disorder, the epidemiology of cannabis use among adolescents and adults in the context of rapidly changing state laws, and evidence-based treatment for the general psychiatrist. The authors provide an overview of pharmacological and psychosocial behavioral treatments for patients with the disorder while emphasizing aspects of clinical management unique to this patient population.